Distribution of Highly Sensitive Troponin in the Critically Unwell & Associated Mortality
DIGNITY
1 other identifier
observational
1,500
1 country
1
Brief Summary
The current diagnostic criteria for a heart attack require evaluation of a patient's symptoms and ECG but importantly a blood test called troponin. With advancing technology this test has become more sensitive and is now called a high sensitivity troponin. This is a very effective way of rapidly excluding a heart attack if the test is negative. However there are a number of causes of a raised high sensitivity other than a heart attack, particularly critical illness states. In the absence of features of a heart attack an abnormal result therefore suggests that the heart is inflamed or unwell causing the release of high sensitivity troponin. The DIGNITY study will examine the consequences of high sensitivity troponin elevation in patients in intensive care and assess whether it has a role as a biomarker for predicting outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 9, 2018
CompletedFirst Posted
Study publicly available on registry
August 14, 2018
CompletedStudy Start
First participant enrolled
January 28, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedJuly 8, 2019
July 1, 2019
8 months
August 9, 2018
July 4, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Association between high sensitivity troponin and inpatient mortality on all patients admitted to each of the ICU environments at a large teaching hospital
During intensive care admission
Secondary Outcomes (4)
Distribution of high sensitivity troponin results for different admissions to intensive care
During intensive care admission
Association between high sensitivity troponin results and duration of ventilation
Within twenty eight days
Association between high sensitivity troponin results and length of intensive care admission
Number of days not in intensive care within twenty eight days of original intensive care admission
Association between high sensitivity troponin results and requirement for inotropic support
During intensive care admission
Study Arms (1)
Intensive care population
All patients admitted to any of the three adult intensive care units (general, cardiac \& neurosciences) at a large teaching hospital. These patients will have a high sensitivity troponin added onto biochemistry samples requested by the clinical team.
Eligibility Criteria
All consecutive patients admitted any of the three adult intensive care units at a large teaching hospital that have at least one biochemistry sample performed as part of their routine care
You may qualify if:
- Adult patients (aged 18 years or older) admitted to any of the three intensive care facilities on site (general, cardiac and neurosciences)
- Biochemistry samples already taken as part of routine clinical care during the ICU stay
You may not qualify if:
- Patients aged less than 18 years
- No biochemistry samples taken within the ICU stay
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Univeristy Hospital Southampton
Southampton, SO16 6YD, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nick Curzen, BM, PhD
University Hospital Southampton NHS Foundation Trust
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 9, 2018
First Posted
August 14, 2018
Study Start
January 28, 2019
Primary Completion
October 1, 2019
Study Completion
October 1, 2019
Last Updated
July 8, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share